Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
ALKBH5 orchestrates ferroptosis-driven tumor suppression: An LLM-powered discovery in prostate cancer | Synapse
March 3, 2026
ALKBH5 orchestrates ferroptosis-driven tumor suppression: An LLM-powered discovery in prostate cancer
XY
Xianyanling Yi
ZH
Zeyu Han
DL
Dazhi Lu
Ver todo
Puntos clave
Ferroptosis significantly contributes to tumor suppression in prostate cancer, enhancing treatment strategies.
A key finding reveals the role of ALKBH5 in regulating molecular pathways associated with ferroptosis.
Analysis utilizes LLM-powered discovery methods to uncover biomarkers related to tumor suppression mechanisms.
This research highlights the need for further studies to validate these findings in clinical settings.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Yi et al. (Sun,) studied this question.
synapsesocial.com/papers/69a768afbadf0bb9e87e5974
https://doi.org/https://doi.org/10.1016/j.ymthe.2026.02.003